Ovarian cancer blood test can detect disease early, study suggests

A new blood test using machine learning has shown promise in detecting ovarian cancer early, which could lead to better patient outcomes. The test is designed to identify signs of the disease in the blood, potentially allowing for earlier diagnosis and treatment. Ovarian cancer is often diagnosed late, making it more challenging to treat. Over 300,000 women, typically over 50, are diagnosed with ovarian cancer globally each year. This new blood test could represent a significant advancement in the early detection of ovarian cancer, which could significantly improve the prognosis for those affected by this disease.
Source: For the complete article, please visit the original source link below.